Study to Evaluate Safety, Tolerability and Pharmacokinetics of Increasing Repeated Oral Doses of Ambroxol Lozenges in Healthy Male Volunteers
Clinical trial NCT02194283 · COMPLETED
Trial details
- NCT number
- NCT02194283
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2009-11-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.